Promising new eczema drug for teens enters final testing phase
NCT ID NCT07042126
First seen Nov 18, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tests a new medication called 611 in Chinese teenagers aged 12 to 17 with moderate-to-severe atopic dermatitis (eczema). The drug aims to reduce skin redness, itching, and rash by blocking a protein involved in inflammation. Participants will receive either 611 or a placebo, and doctors will measure improvements in skin symptoms over 16 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine
RECRUITINGNanchang, Zhejiang, 310003, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Fourth Affiliated Hospital Zhejiang University School of Medicine
RECRUITINGJinhua, Zhejiang, 322000, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.